DEA Reschedules Hydrocodone Combination Products

Posted in Latest News on September 26, 2014.

On Friday, August 22nd, the U. S. Drug Enforcement Administration (DEA) published a Final Rule moving hydrocodone combination products (HCPs) from Schedule III to the more-restrictive Schedule II. This Final Rule imposes the regulatory controls and sanctions applicable to Schedule II substances on those who handle or propose to handle HCPs. The rule goes into effect 45 days from its publish date.

The entire rule text may be found here:  https://www.federalregister.gov/articles/2014/08/22/2014-19922/schedules-of-controlled-substances-rescheduling-of-hydrocodone-combination-products-from-schedule

Frequently Asked Questions regarding this change may be found here: Hydrocodone FAQs



More Latest News

NTSB Study on Drug Use Trends in Aviation
March 8, 2021

National Transportation Safety Board issues recommendations to states on prescribing controlled substances for pain and the dangers of operating a vehicle in any mode of transportation Continue reading


Second Quarter Performance Report
March 4, 2021

Released for Fiscal Year
2020-2021 Continue reading